IP Library Granted Patent US 11,986,658
Granted Patent B2
US 11,986,658 · App. 17/518,414 · Granted May 21, 2024

Implantable electrodes with remote power delivery for treating sleep apnea, and associated systems and methods

Inventors: Richard W. O'Connor (Atherton, CA); Walter Joseph Stevens (San Jose, CA); Timothy A. Fayram (Gilroy, CA)
Assignee: Invicta Medical, Inc.
A61N1/3611A61N1/0548A61N1/0558A61N1/36139A61N1/36153A61N1/36157A61N1/36171A61N1/36175A61N1/37205A61N1/3787H02J50/20
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,986,658
App. No.
17/518,414
Granted
May 21, 2024
Kind
B2
Abstract

Implantable electrodes with power delivery wearable for treating sleep apnea, and associated systems and methods are disclosed herein. A representative system includes non-implantable signal generator worn by the patient and having an antenna that directs a mid-field RF power signal to an implanted electrode. The implanted electrode in turn directs a lower frequency signal to a neural target, for example, the patient's hypoglossal nerve. Representative signal generators can have the form of a mouthpiece, a collar or other wearable, and/or a skin-mounted patch.

Claims (49)

1. A patient treatment system, comprising:

a wearable device carrying:

a power storage device;

a power transmission antenna coupled to the power storage device and configured to emit a power signal; and

first control circuitry coupled between the power storage device and the power transmission antenna; and

a percutaneously implantable device having:

an electrode;

a housing carrying the electrode;

an electrode receiver antenna configured to receive the power signal;

one or more charge storage devices having a total charge storage capacity of no more than 5 minutes;

a signal generator coupled to (i) the electrode receiver antenna to receive the power signal therefrom and (ii) the electrode to direct a signal to the electrode at a frequency in a range of 10 Hz to 300 Hz; and

second circuitry coupled between the signal generator and the electrode to control delivery of the signal to the electrode.

2. The system of claim 1 , wherein the implantable device is a needle-deliverable device, and wherein the electrode is positioned to be implanted proximate to a patient's hypoglossal nerve and/or ansa cervicalis, and wherein the system further comprises:

at least one sensor carried by the wearable device or the implantable device, the at least one sensor being configured to detect a characteristic of the patient's respiratory performance; and

a controller carried by the wearable device and programmed with instructions that, when executed, initiate, change, and/or halt the delivery of the signal to the electrode, based at least in part on information received from the at least one sensor.

3. The system of claim 2 wherein the at least one sensor includes a pulse oximeter, a photoplethysmography sensor, and a patient orientation sensor.

4. The system of claim 1 wherein the implantable device does not include a battery and/or a power capacitor.

5. The system of claim 1 wherein the electrode is a first electrode, and wherein the implantable device includes a second electrode, and wherein at least one of the first circuitry or the second circuitry include instructions that, when executed, direct signals to the first and second electrodes that are sequenced, with the first electrode delivering a first signal to the patient at a first point in time, and the second electrode delivering a second signal to the patient at a second point in time.

6. The system of claim 1 wherein the wearable device includes an intraoral device configured to be positioned within the patient's oral cavity.

7. The system of claim 6 wherein at least a first portion of the intraoral device is shaped to conform to at least a second portion of the patient's oral cavity.

8. The system of claim 6 wherein the intraoral device includes an upper mouthpiece portion, a lower mouthpiece portion and a connector coupling the upper and lower mouthpiece portions.

9. The system of claim 8 wherein the lower mouthpiece portion is movable relative to the upper mouthpiece portion to advance the patient's mandible.

10. The system of claim 8 wherein the lower mouthpiece portion carries the power transmission antenna, the power storage device, and the first circuitry.

11. The system of claim 8 wherein the lower mouthpiece portion carries the power transmission antenna and the upper mouthpiece portion carries the power storage device and the first circuitry.

12. The system of claim 11 wherein the upper mouthpiece portion includes a roof portion that carries the power storage device or the first circuitry.

13. The system of claim 8 wherein the lower mouthpiece portion carries the power storage device, the upper mouthpiece portion carries the first circuitry, and the connector includes a communication link to transmit power from the power storage device to the first circuitry.

14. The system of claim 8 wherein at least a part of the lower mouthpiece portion is shaped to conform to a lower region of the patient's oral cavity.

15. The system of claim 8 wherein at least a part of the upper mouthpiece portion is shaped to conform to an upper region of the patient's oral cavity.

16. The system of claim 1 wherein (i) the implantable device is a first implantable device positioned on a first side of the patient's oral cavity and (ii) the electrode is a first electrode, the system further comprising a second implantable device positioned on a second side of the patient's oral cavity opposite the first implantable device, the second implantable device including a second electrode.

17. The system of claim 1 wherein the wearable device includes at least one of a neck collar, a chinstrap, a pillow, and/or a mattress overlay.

18. The system of claim 1 wherein at least one of the first circuitry or the second circuitry include instructions that, when executed, cause the electrode to deliver a signal to the patient, wherein the signal includes at least one of:

a pulse width between 30 μs and 300 μs;

an anodic amplitude between 1 mA and 6 mA or between 1 mV and 5 V; and

a cathodic amplitude between 1 mA and 6 mA or between 1 mV and 5 V.

19. The system of claim 1 wherein the wearable device further includes at least one sensor positioned to detect at least one physiological parameter of the patient, the at least one physiological parameter including at least one of a respiratory rate, a heart rate, an audio signal, a body temperature, a head position, a saturated blood oxygen level, an air flow level, movement of the patient's larynx, and/or movement of the patient's tongue.

20. The system of claim 1 wherein the power signal is an RF signal having a frequency in a frequency range of 300 MHz to 6 GHz.

21. A patient treatment system, comprising:

a wearable device including a power transmission device configured to emit a power signal; and

a signal delivery device including:

an electrode;

a housing carrying the electrode and configured to be percutaneously implantable;

a power reception device positioned within the housing and configured to receive the power signal from the power transmission device;

a signal generator positioned within the housing and operably coupled to (i) the power reception device to receive power therefrom and (ii) the electrode to cause the electrode to deliver a signal to a target tissue of the patient, the signal having a frequency in a range of 10 Hz to 300 Hz; and

one or more charge storage devices having a total charge storage capacity of no more than 5 minutes.

22. The system of claim 21 wherein the target tissue includes a hypoglossal nerve of the patient.

23. The system of claim 21 wherein the housing is configured to be percutaneously injectable.

24. The system of claim 21 wherein the housing is configured to be implanted within the patient via a percutaneous injection needle.

25. The system of claim 21 wherein the power transmission device includes an inductive coil.

26. The system of claim 21 wherein the power transmission device includes an RF antenna.

Assignments (4)
CHANGE OF NAME Recorded May 4, 2026
From: INVICTA MEDICAL, INC.
To: RESTERA, INC.
Reel/Frame 075500/0014 →
RELEASE OF SECURITY INTEREST Recorded Aug 13, 2025
From: APHELION CAPITAL, LLC, AS COLLATERAL AGENT
To: INVICTA MEDICAL, INC.
Reel/Frame 072014/0302 →
SECURITY INTEREST Recorded Feb 11, 2025
From: INVICTA MEDICAL, INC.
To: APHELION CAPITAL, LLC, AS COLLATERAL AGENT
Reel/Frame 070176/0383 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 14, 2022
From: O'CONNOR, RICHARD W.; STEVENS, WALTER JOSEPH; FAYRAM, TIMOTHY A.
To: INVICTA MEDICAL, INC.
Reel/Frame 058665/0820 →
Continuity (2)
Provisional Application 63109809 · Nov 4, 2020
Related Publication 20220134102A1 · May 5, 2022
Cited By (1)
US 12,397,160